Publication Name	World Journal of Nephrology
Manuscript ID	99802
Country	India

Received	2024-07-30 17:28
Peer-Review Started	2024-07-30 17:28
To Make the First Decision
Return for Revision	2024-09-17 04:04
Revised	2024-10-16 08:42
Second Decision	2024-11-11 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-12 08:05
Articles in Press	2024-11-12 08:05
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-11-15 15:19
Typeset the Manuscript	2024-11-30 06:14
Publish the Manuscript Online	2025-01-20 08:27

ISSN	2220-6124 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Minireviews
Article Title	Current role of biomarkers in the initiation and weaning of kidney replacement therapy in acute kidney injury
Manuscript Source	Invited Manuscript
All Author List	Kanwalpreet Sodhi, Gunjan Chanchalani and Niraj Tyagi
ORCID	Author(s) ORCID Number Kanwalpreet Sodhi http://orcid.org/0000-0002-7377-9225 Gunjan Chanchalani http://orcid.org/0000-0001-8429-8526 Niraj Tyagi http://orcid.org/0000-0001-5862-9731
Funding Agency and Grant Number
Corresponding Author	Kanwalpreet Sodhi, Department of Critical Care, Deep Hospital, Model Town, Ludhiana 141001, Punjab, India. drkanwal2006@yahoo.com
Key Words	Biomarker; Neutrophil gelatinase-associated lipocalin; Kidney replacement therapy; Proenkephalin 119–159; Acute kidney injury; Cystatin C
Core Tip	Routinely more than 50% of patients with acute kidney injury in intensive care unit require kidney replacement therapy (KRT). But there are no clearcut guiding parameters on timing of initiation or weaning from KRT. Biomarkers have a promising role in initiation of KRT and can be employed in weaning decision from KRT. In this narrative review we summarise the individual roles of biomarkers and the supportive literature.
Publish Date	2025-01-20 08:27
Citation	<p>Sodhi K, Chanchalani G, Tyagi N. Current role of biomarkers in the initiation and weaning of kidney replacement therapy in acute kidney injury. <i>World J Nephrol</i> 2025; 14(1): 99802</p>
URL	https://www.wjgnet.com/2220-6124/full/v14/i1/99802.htm
DOI	https://dx.doi.org/10.5527/wjn.v14.i1.99802

Full Article (PDF)	WJN-14-99802-with-cover.pdf
Manuscript File	99802_Auto_Edited_032350.docx
Answering Reviewers	99802-answering-reviewers.pdf
Audio Core Tip	99802-audio.m4a
Conflict-of-Interest Disclosure Form	99802-conflict-of-interest-statement.pdf
Copyright License Agreement	99802-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	99802-non-native-speakers.pdf
Peer-review Report	99802-peer-reviews.pdf
Scientific Misconduct Check	99802-scientific-misconduct-check.png
Scientific Editor Work List	99802-scientific-editor-work-list.pdf
CrossCheck Report	99802-crosscheck-report.pdf